Bio

Bio


Dr. Elizabeth Bailey is a Clinical Assistant Professor of Dermatology at Stanford and acts as Associate Program Director for the Stanford Dermatology Residency Program and Director of Global Health Dermatology.

Dr. Bailey graduated magna cum laude from Harvard University and received her medical degree from Columbia University in New York, where she was a member of the Alpha Omega Alpha honor society. She completed her internship in internal medicine at Brigham and Women’s Hospital in Boston, and completed both her residency in dermatology and fellowship in dermatopathology at Stanford University Medical Center. She is board certified in dermatology and dermatopathology by the American Boards of Dermatology/Pathology.

Dr. Bailey's academic interests include medical education, community outreach, global health, and skin cancer detection and prevention.

Clinical Focus


  • Dermatology
  • Skin cancer detection and prevention
  • Adult general dermatology
  • Dermatopathology

Academic Appointments


Administrative Appointments


  • Associate Program Director of Dermatology Residency Program, Department of Dermatology (2018 - Present)
  • Assistant Program Director of Dermatology Residency Program, Department of Dermatology (2016 - 2018)

Boards, Advisory Committees, Professional Organizations


  • Member, San Francisco Dermatological Society (2012 - Present)
  • Member, American Medical Association (2012 - Present)
  • Fellow, American Academy of Dermatology (2016 - Present)
  • Fellow, Center for Innovation in Global Health, Stanford University School of Medicine (2016 - Present)
  • Member, American Society of Dermatopathology (2016 - Present)
  • Member, Women's Dermatologic Society (2017 - Present)
  • Member, Association of Professors of Dermatology (2018 - Present)

Professional Education


  • Internship:Brigham and Women's Hospital Internal Medicine Residency (2012) MA
  • Residency:Stanford University Dermatology Residency (2015) CA
  • Fellowship:Stanford University Pathology Residency (2016) CA
  • Board Certification: Dermatopathology, American Board of Dermatology (2016)
  • Board Certification, American Board of Dermatology, Dermatology (2015)
  • Fellowship, Dermatopathology, Stanford Hospital and Clinics, CA (2016)
  • Residency, Dermatology, Stanford Hospital and Clinics, CA (2015)
  • Internship, Brigham and Women's Hospital, MA (2012)
  • MD, Columbia University College of Physicians and Surgeons, NY (2011)
  • MPH, Harvard School of Public Health, MA (2011)
  • AB, Harvard College, magna cum laude (2006)

Community and International Work


  • Capacity-building in dermatology at Dhulikhel Hospital, Dhulikhel, Nepal, Dhulikhel, Nepal

    Topic

    Dermatology and Dermatopathology Consultation and Capacity-building

    Partnering Organization(s)

    Center for Innovation in Global Health, Stanford University

    Location

    International

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    Yes

  • International clinical experience, Gaborone, Botswana

    Topic

    Dermatology clinical care and medical education

    Partnering Organization(s)

    American Academy of Dermatology

    Populations Served

    Patients seen within Botswana national health service

    Location

    International

    Ongoing Project

    No

    Opportunities for Student Involvement

    No

  • Volunteer Physician at Stanford Cardinal Free Clinics

    Location

    Bay Area

    Ongoing Project

    Yes

    Opportunities for Student Involvement

    Yes

Publications

All Publications


  • Outcomes of surgical re-excision versus observation of severely dysplastic nevi: a single institution, retrospective cohort study. Journal of the American Academy of Dermatology Fleming, N. H., Shaub, A. R., Bailey, E., Swetter, S. M. 2019

    View details for DOI 10.1016/j.jaad.2019.07.033

    View details for PubMedID 31325549

  • A growing nodule on the forearm of an 84-year-old man. Journal of cutaneous pathology Bailey, E. E., Rushovich, A. M., Kim, J. 2017; 44 (1): 1-4

    View details for DOI 10.1111/cup.12816

    View details for PubMedID 28000246

  • Limited Role of Random Skin Biopsy in the Diagnosis of Intravascular Lymphoma in Adult Patients with Hemophagocytic Lymphohistiocytosis ACTA HAEMATOLOGICA Cho, H. G., Sheu, S. L., Kuo, K. Y., Ally, M. S., Bailey, E. E., Kim, J., Kwong, B. Y. 2017; 138 (1): 33–38

    Abstract

    This study examined the role of random normal skin biopsy in the diagnosis of intravascular lymphoma (IVL) in adult Western patients with clinically diagnosed hemophagocytic lymphohistiocytosis (HLH).In a retrospective chart review study, we analyzed a total of 59 skin biopsies that were performed to diagnose IVL in 21 adult patients with HLH seen at Stanford Hospital between 2004 and 2016.Out of the 59 skin biopsies, 42 were taken from clinically normal-appearing skin and 17 from clinically abnormal-appearing skin. None of the 59 biopsies revealed a diagnosis of primary or metastatic malignancy, regardless of the malignancy history, clinical presentation, and biopsy and histopathologic characteristics. A review of 8 positive IVL cases at Stanford Hospital including 1 case associated with HLH showed 1 positive diagnosis by a targeted skin biopsy and other positive diagnoses by bone marrow (n = 4), lung (n = 2), brain (n = 2), muscle (n = 1), and nerve (n = 1).Random skin biopsies have a limited role in diagnosing IVL in adult patients with HLH, in the setting of a single academic institution in the USA. A review of the literature emphasizes the role of a full body skin exam with a selective skin biopsy in these patients.

    View details for PubMedID 28668948

  • Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management CURRENT RHEUMATOLOGY REPORTS Bailey, E. E., Fiorentino, D. F. 2014; 16 (12)

    Abstract

    Amyopathic dermatomyositis can be a challenging diagnosis because patients lack traditional muscle findings. "Clinically amyopathic" dermatomyositis (CADM) accounts for the presence of subclinical muscle disease in some of these patients. These patients represent a substantial minority of dermatomyositis cases and have similar co-morbidities to "classic" dermatomyositis patients, including interstitial lung disease and malignancy. Clinically amyopathic dermatomyositis patients should not be considered as a distinct clinical entity from "classic" dermatomyositis, as they share antibody sub-types and associated co-morbidities, likely representing clinical spectrum of a common disease. It is essential for the clinician to be familiar with the clinical presentation of clinically amyopathic dermatomyositis, in order to facilitate early, accurate diagnosis and appropriate clinical management.

    View details for DOI 10.1007/s11926-014-0465-0

    View details for Web of Science ID 000344648600001

    View details for PubMedID 25366932

  • Skin Cancer Education among Massage Therapists: A Survey at the 2010 Meeting of the American Massage Therapy Association JOURNAL OF CANCER EDUCATION Campbell, S. M., Louie-Gao, Q., Hession, M. L., Bailey, E., Geller, A. C., Cummins, D. 2013; 28 (1): 158-164

    Abstract

    Massage therapists encounter skin on a daily basis and have a unique opportunity to recognize potential skin cancers. The purpose of this study was to describe the skin cancer education provided to massage therapists and to assess their comfort regarding identification and communication of suspicious lesions. An observational retrospective survey study was conducted at the 2010 American Massage Therapy Association Meeting. Sixty percent reported receiving skin cancer education during and 25% reported receiving skin cancer education after training. Massage therapists who examine their own skin are more likely to be comfortable with recognizing a suspicious lesion and are more likely to examine their client's skin. Greater number of clients treated per year and greater frequency of client skin examinations were predictors of increased comfort level with recognizing a suspicious lesion. Massage therapists are more comfortable discussing than identifying a potential skin cancer. Massage therapists may be able to serve an important role in the early detection of skin cancer.

    View details for DOI 10.1007/s13187-012-0403-7

    View details for Web of Science ID 000316820900024

    View details for PubMedID 22915212

  • Combination Treatments for Psoriasis A Systematic Review and Meta-analysis ARCHIVES OF DERMATOLOGY Bailey, E. E., Ference, E. H., Alikhan, A., Hession, M. T., Armstrong, A. W. 2012; 148 (4): 511-522

    Abstract

    To summarize the current state of evidence for combination topical and systemic therapies for mild to severe psoriasis.We performed a systematic search for all entries in PubMed, CINAHL, Cochrane Review, and EMBASE related to combination treatments for psoriasis through July 2010.We included randomized controlled trials that reported proportion of disease clearance or mean change in clinical severity score (or provided these data through communication with study authors) for efficacy of a combination treatment for psoriasis compared with 1 or more corresponding monotherapies.Study data were extracted by 3 independent investigators, with disagreement resolved by consensus. The proportion of patients who achieved clearance, definition of clearance, means and standard deviations for baseline disease symptom score and final disease symptom score, and major design characteristics were extracted for each study.Combination treatments consisting of vitamin D derivative and corticosteroid, vitamin D derivative and UV-B, vitamin A derivative and psoralen-UV-A, vitamin A derivative and corticosteroid, vitamin A derivative and UV-B, corticosteroid and hydrocolloid occlusion dressings, UV-B and alefacept, and vitamins A and D derivatives were more effective than 1 or more monotherapies using the likelihood of clearance as the outcome. Blinding status and potency of the corticosteroid treatment used were significant sources of heterogeneity between studies.The results demonstrate the need for additional long-term trials with standardized outcome measures to evaluate the efficacy and adverse effects of combination therapies for psoriasis and highlight the possible effects of trial design characteristics on results.

    View details for DOI 10.1001/archdermatol.2011.1916

    View details for Web of Science ID 000302870600016

    View details for PubMedID 22184718

  • Skin Cancer Knowledge, Attitudes, and Behaviors in the Salon A Survey of Working Hair Professionals in Houston, Texas ARCHIVES OF DERMATOLOGY Bailey, E. E., Marghoob, A. A., Orengo, I. F., Testa, M. A., White, V. R., Geller, A. C. 2011; 147 (10): 1159-1165

    Abstract

    To determine factors related to the observation of suspicious lesions on the scalp, neck, and face of customers by hair professionals (cosmetologists and barbers).Survey of hair professionals in January 2010.Single hair professional educational conference.Hair professionals from a chain of 17 salons in the greater Houston, Texas, area.Frequency with which hair professionals looked for lesions on their customers' scalp, neck, and face during the previous month.Of 304 surveys distributed to hair professionals, 203 were completed (66.8% response rate). Few hair professionals had received formal skin cancer education (28.1%). Forty-nine percent of hair professionals were "very" or "extremely" interested in participating in a skin cancer education program. Of responding participants, 37.1% looked at more than 50% of their customers' scalps, 28.8% looked at more than 50% of their customers' necks, and 15.3% looked at more than 50% of their customers' faces for suspicious lesions during the preceding month. Frequency of observation of customers' lesions was associated with hair professionals' self-reported health communication practices (P < .001) and personal skin protection practices (P = .05) but was not associated with hair professionals' skin cancer knowledge (P = .48).This study suggests that hair professionals are looking for suspicious lesions on customers' scalp, neck, and face and are acting as lay skin cancer educators. These results provide evidence that hair professionals would be receptive to skin cancer education and that further investigation into the role of hair professionals in skin cancer prevention and detection campaigns is needed.

    View details for Web of Science ID 000295944300005

    View details for PubMedID 22006132

  • Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: hypothesis for a paraneoplastic phenomenon EUROPEAN JOURNAL OF DERMATOLOGY Young, A. L., Bailey, E. E., Colaco, S. M., Engler, D. E., Grossman, M. E. 2011; 21 (3): 401-404

    Abstract

    Anti-epiligrin cicatricial pemphigoid is an autoimmune blistering disorder that has recently been associated with the development of solid organ malignancy. We describe a patient with recurrent metastatic prostate carcinoma who was diagnosed with this disorder. We provide a hypothesis as to the relationship between the development of this disease and its possible association with cancer pathogenesis.

    View details for DOI 10.1684/ejd.2011.1360

    View details for Web of Science ID 000293836300014

    View details for PubMedID 21527374

  • Cellulitis: diagnosis and management DERMATOLOGIC THERAPY Bailey, E., Kroshinsky, D. 2011; 24 (2): 229-239

    Abstract

    Cellulitis is an acute infection of the dermal and subcutaneous layers of the skin, often occurring after a local skin trauma. It is a common diagnosis in both inpatient and outpatient dermatology, as well as in the primary care setting. Cellulitis classically presents with erythema, swelling, warmth, and tenderness over the affected area. There are many other dermatologic diseases, which can present with similar findings, highlighting the need to consider a broad differential diagnosis. Some of the most common mimics of cellulitis include venous stasis dermatitis, contact dermatitis, deep vein thrombosis, and panniculitis. History, local characteristics of the affected area, systemic signs, laboratory tests, and, in some cases, skin biopsy can be helpful in confirming the correct diagnosis. Most patients can be treated as an outpatient with oral antibiotics, with dicloxacillin or cephalexin being the oral therapy of choice when methicillin-resistant Staphylococcus aureus is not a concern.

    View details for DOI 10.1111/j.1529-8019.2011.01398.x

    View details for Web of Science ID 000288455800008

    View details for PubMedID 21410612